🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Multiple myeloma (MM) is an incurable malignancy and accounts for 1 percent...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-06-18
Trial ID
NCT03525678
Treatments Being Tested
This is a phase I/II, single arm, open label, two-part study that will asse...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-03-14
Trial ID
NCT03848845
Treatments Being Tested
This study will evaluate the efficacy and safety of belantamab mafodotin in...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2020-10-01
Trial ID
NCT04484623
Treatments Being Tested
Belantamab mafodotin is an antibody-drug conjugate (ADC) containing humaniz...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2020-10-09
Trial ID
NCT04398745
Treatments Being Tested
This study is designed to evaluate safety and efficacy of belantamab mafodo...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2021-07-28
Trial ID
NCT06868667
Treatments Being Tested
This open-label, randomized study for evaluating the efficacy and safety of...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2020-04-02
Trial ID
NCT04162210
Treatments Being Tested
This study will evaluate the safety, pharmacokinetics, pharmacodynamics and...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2019-12-18
Trial ID
NCT04091126
Treatments Being Tested
The DREAMM project is investigating whether the DREAMM interventions (1) He...
Status
Completed
Location
Hôpital Central Yaoundé
Start Date
2016-04-23
Trial ID
NCT03226379
Treatments Being Tested
This study is designed to evaluate safety and efficacy of belantamab mafodo...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2021-07-28
Trial ID
NCT06868654
Treatments Being Tested
B-cell maturation antigen (BCMA) is a target present on tumor cells in part...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2019-10-07
Trial ID
NCT04126200